Zobrazeno 1 - 10
of 288
pro vyhledávání: '"Giffard F"'
Autor:
Neviere Z; Department of Medical Oncology, Comprehensive Cancer Centre F. Baclesse, UNICANCER, Caen, France., Blanc-Fournier C; Department of Bio-Pathology, Comprehensive Cancer Centre F. Baclesse, UNICANCER, Caen, France., Guizard AV; Calvados General Tumour Registry, Cancers & Préventions - U1086 Inserm, Centre François Baclesse, Caen, France., Elie N; Federative Structure 4207 'Normandie Oncologie', PLATON Services Unit, VIRTUAL'HIS, Université de Caen Normandie, Caen, France., Giffard F; Federative Structure 4207 'Normandie Oncologie', PLATON Services Unit, VIRTUAL'HIS, Université de Caen Normandie, Caen, France.; Interdisciplinary Research Unit for Cancer Prevention and Treatment, Federative Structure 4207 'Normandie Oncologie', F. Baclesse, Université of Caen Normandie, Inserm U1086 ANTICIPE, Caen, France., Lequesne J; Biostatistics Department, Comprehensive Cancer Centre François Baclesse, UNICANCER, Caen, France., Emile G; Department of Medical Oncology, Comprehensive Cancer Centre F. Baclesse, UNICANCER, Caen, France., Poulain L; Interdisciplinary Research Unit for Cancer Prevention and Treatment, Federative Structure 4207 'Normandie Oncologie', F. Baclesse, Université of Caen Normandie, Inserm U1086 ANTICIPE, Caen, France., Lasnon C; Interdisciplinary Research Unit for Cancer Prevention and Treatment, Federative Structure 4207 'Normandie Oncologie', F. Baclesse, Université of Caen Normandie, Inserm U1086 ANTICIPE, Caen, France. c.lasnon@baclesse.unicancer.fr.; Nuclear Medicine Department, Comprehensive Cancer Centre François Baclesse, UNICANCER, 3 Avenue du General Harris, BP 45026, Caen, 14076, France. c.lasnon@baclesse.unicancer.fr.
Publikováno v:
BMC cancer [BMC Cancer] 2024 Oct 29; Vol. 24 (1), pp. 1328. Date of Electronic Publication: 2024 Oct 29.
Autor:
Laurent-Issartel C; Equipe de Recherche sur Les Relations Matrice Extracellulaire-Cellules, ERRMECe, (EA1391), Groupe Matrice Extracellulaire et Physiopathologie (MECuP), Institut des Materiaux, I-MAT (FD4122), CY Cergy Paris Université, France., Landras A; Equipe de Recherche sur Les Relations Matrice Extracellulaire-Cellules, ERRMECe, (EA1391), Groupe Matrice Extracellulaire et Physiopathologie (MECuP), Institut des Materiaux, I-MAT (FD4122), CY Cergy Paris Université, France., Agniel R; Equipe de Recherche sur Les Relations Matrice Extracellulaire-Cellules, ERRMECe, (EA1391), Groupe Matrice Extracellulaire et Physiopathologie (MECuP), Institut des Materiaux, I-MAT (FD4122), CY Cergy Paris Université, France., Giffard F; UNICANCER, F. Baclesse Comprehensive Cancer Center, Biopathology Department, Caen, France; Université de Caen Normandie, Inserm U1086 ANTICIPE, Caen, France; Université de Caen Normandie, Unité de Services PLATON, Plateforme Virtual'His, Caen, France., Blanc-Fournier C; UNICANCER, F. Baclesse Comprehensive Cancer Center, Biopathology Department, Caen, France; Université de Caen Normandie, Unité de Services PLATON, Centre de Ressources Biologiques OvaRessources, Caen, France., Da Silva Cruz E; University of Strasbourg, Laboratory of Bioimaging and Pathologies, UMR CNRS 7021, Illkirch, France., Habes C; Equipe de Recherche sur Les Relations Matrice Extracellulaire-Cellules, ERRMECe, (EA1391), Groupe Matrice Extracellulaire et Physiopathologie (MECuP), Institut des Materiaux, I-MAT (FD4122), CY Cergy Paris Université, France., Leroy-Dudal J; Equipe de Recherche sur Les Relations Matrice Extracellulaire-Cellules, ERRMECe, (EA1391), Groupe Matrice Extracellulaire et Physiopathologie (MECuP), Institut des Materiaux, I-MAT (FD4122), CY Cergy Paris Université, France., Carreiras F; Equipe de Recherche sur Les Relations Matrice Extracellulaire-Cellules, ERRMECe, (EA1391), Groupe Matrice Extracellulaire et Physiopathologie (MECuP), Institut des Materiaux, I-MAT (FD4122), CY Cergy Paris Université, France., Kellouche S; Equipe de Recherche sur Les Relations Matrice Extracellulaire-Cellules, ERRMECe, (EA1391), Groupe Matrice Extracellulaire et Physiopathologie (MECuP), Institut des Materiaux, I-MAT (FD4122), CY Cergy Paris Université, France. Electronic address: sabrina.kellouche@cyu.fr.
Publikováno v:
Experimental cell research [Exp Cell Res] 2024 Aug 01; Vol. 441 (1), pp. 114155. Date of Electronic Publication: 2024 Jul 16.
Autor:
Tomasina, J., Poulain, L., Abeilard, E., Giffard, F., Brotin, E., Carduner, L., Carreiras, F., Gauduchon, P., Rault, S., Malzert-Fréon, A.
Publikováno v:
In International Journal of Pharmaceutics 15 December 2013 458(1):197-207
Autor:
Dolivet E; ANTICIPE UMR (1086) (Interdisciplinary Research Unit for Cancers Prevention and Treatment), BioTICLA Laboratory (Precision Medicine in Ovarian Carcinoma), Federative Structure 4207 Normandie Oncologie, Université de Caen Normandie, Inserm, F-14000 Caen, France.; Unicancer, Comprehensive Cancer Center F. Baclesse, 3 Avenue Général Harris, F-14000 Caen, France., Gaichies L; ANTICIPE UMR (1086) (Interdisciplinary Research Unit for Cancers Prevention and Treatment), BioTICLA Laboratory (Precision Medicine in Ovarian Carcinoma), Federative Structure 4207 Normandie Oncologie, Université de Caen Normandie, Inserm, F-14000 Caen, France.; Unicancer, Comprehensive Cancer Center F. Baclesse, 3 Avenue Général Harris, F-14000 Caen, France., Jeanne C; Unicancer, Comprehensive Cancer Center F. Baclesse, 3 Avenue Général Harris, F-14000 Caen, France., Bazille C; Department of Pathology, Caen University Hospital, F-14000 Caen, France., Briand M; ANTICIPE UMR (1086) (Interdisciplinary Research Unit for Cancers Prevention and Treatment), BioTICLA Laboratory (Precision Medicine in Ovarian Carcinoma), Federative Structure 4207 Normandie Oncologie, Université de Caen Normandie, Inserm, F-14000 Caen, France.; Unicancer, Comprehensive Cancer Center F. Baclesse, 3 Avenue Général Harris, F-14000 Caen, France.; Unicancer, Comprehensive Cancer Center F. Baclesse, Biological Ressources Centre OvaRessouces, F-14000 Caen, France., Vernon M; ANTICIPE UMR (1086) (Interdisciplinary Research Unit for Cancers Prevention and Treatment), BioTICLA Laboratory (Precision Medicine in Ovarian Carcinoma), Federative Structure 4207 Normandie Oncologie, Université de Caen Normandie, Inserm, F-14000 Caen, France.; Unicancer, Comprehensive Cancer Center F. Baclesse, 3 Avenue Général Harris, F-14000 Caen, France., Giffard F; ANTICIPE UMR (1086) (Interdisciplinary Research Unit for Cancers Prevention and Treatment), BioTICLA Laboratory (Precision Medicine in Ovarian Carcinoma), Federative Structure 4207 Normandie Oncologie, Université de Caen Normandie, Inserm, F-14000 Caen, France.; Unicancer, Comprehensive Cancer Center F. Baclesse, 3 Avenue Général Harris, F-14000 Caen, France.; Services Unit PLATON, Virtual'his Core Facility, Université de Caen Normandie, F-14000 Caen, France., Leprêtre F; CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, US 41-UAR 2014-PLBS, University of Lille, F-59000 Lille, France., Poulain L; ANTICIPE UMR (1086) (Interdisciplinary Research Unit for Cancers Prevention and Treatment), BioTICLA Laboratory (Precision Medicine in Ovarian Carcinoma), Federative Structure 4207 Normandie Oncologie, Université de Caen Normandie, Inserm, F-14000 Caen, France.; Unicancer, Comprehensive Cancer Center F. Baclesse, 3 Avenue Général Harris, F-14000 Caen, France.; Unicancer, Comprehensive Cancer Center F. Baclesse, Biological Ressources Centre OvaRessouces, F-14000 Caen, France., Denoyelle C; ANTICIPE UMR (1086) (Interdisciplinary Research Unit for Cancers Prevention and Treatment), BioTICLA Laboratory (Precision Medicine in Ovarian Carcinoma), Federative Structure 4207 Normandie Oncologie, Université de Caen Normandie, Inserm, F-14000 Caen, France.; Unicancer, Comprehensive Cancer Center F. Baclesse, 3 Avenue Général Harris, F-14000 Caen, France., Vigneron N; ANTICIPE UMR (1086) (Interdisciplinary Research Unit for Cancers Prevention and Treatment), BioTICLA Laboratory (Precision Medicine in Ovarian Carcinoma), Federative Structure 4207 Normandie Oncologie, Université de Caen Normandie, Inserm, F-14000 Caen, France.; Unicancer, Comprehensive Cancer Center F. Baclesse, 3 Avenue Général Harris, F-14000 Caen, France.; Unicancer, Comprehensive Cancer Center F. Baclesse, Calvados General Tumor Registry, F-14000 Caen, France., Fauvet R; ANTICIPE UMR (1086) (Interdisciplinary Research Unit for Cancers Prevention and Treatment), BioTICLA Laboratory (Precision Medicine in Ovarian Carcinoma), Federative Structure 4207 Normandie Oncologie, Université de Caen Normandie, Inserm, F-14000 Caen, France.; Department of Obstetrics and Reproductive Medicine, Université de Caen Normandie, F-14000 Caen, France.
Publikováno v:
International journal of molecular sciences [Int J Mol Sci] 2023 Nov 06; Vol. 24 (21). Date of Electronic Publication: 2023 Nov 06.
Autor:
Thorel L; Université de Caen Normandie, INSERM U1086 ANTICIPE (Interdisciplinary Research Unit for Cancers Prevention and Treatment), BioTICLA Laboratory (Precision Medicine for Ovarian Cancers), 3 Avenue du Général Harris, BP 45026, 14 076, Caen, Cedex 05, France., Morice PM; Université de Caen Normandie, INSERM U1086 ANTICIPE (Interdisciplinary Research Unit for Cancers Prevention and Treatment), BioTICLA Laboratory (Precision Medicine for Ovarian Cancers), 3 Avenue du Général Harris, BP 45026, 14 076, Caen, Cedex 05, France., Paysant H; Université de Caen Normandie, INSERM U1086 ANTICIPE (Interdisciplinary Research Unit for Cancers Prevention and Treatment), BioTICLA Laboratory (Precision Medicine for Ovarian Cancers), 3 Avenue du Général Harris, BP 45026, 14 076, Caen, Cedex 05, France., Florent R; Université de Caen Normandie, INSERM U1086 ANTICIPE (Interdisciplinary Research Unit for Cancers Prevention and Treatment), BioTICLA Laboratory (Precision Medicine for Ovarian Cancers), 3 Avenue du Général Harris, BP 45026, 14 076, Caen, Cedex 05, France.; Université de Caen Normandie, Services Unit PLATON, ORGAPRED Core Facility, Caen, France.; UNICANCER, Comprehensive Cancer Center François Baclesse, Caen, France., Babin G; Université de Caen Normandie, INSERM U1086 ANTICIPE (Interdisciplinary Research Unit for Cancers Prevention and Treatment), BioTICLA Laboratory (Precision Medicine for Ovarian Cancers), 3 Avenue du Général Harris, BP 45026, 14 076, Caen, Cedex 05, France.; UNICANCER, Comprehensive Cancer Center Francois Baclesse, Department of Surgery, Caen, France., Thomine C; Université de Caen Normandie, INSERM U1086 ANTICIPE (Interdisciplinary Research Unit for Cancers Prevention and Treatment), BioTICLA Laboratory (Precision Medicine for Ovarian Cancers), 3 Avenue du Général Harris, BP 45026, 14 076, Caen, Cedex 05, France., Perréard M; Université de Caen Normandie, INSERM U1086 ANTICIPE (Interdisciplinary Research Unit for Cancers Prevention and Treatment), BioTICLA Laboratory (Precision Medicine for Ovarian Cancers), 3 Avenue du Général Harris, BP 45026, 14 076, Caen, Cedex 05, France., Abeilard E; Université de Caen Normandie, INSERM U1086 ANTICIPE (Interdisciplinary Research Unit for Cancers Prevention and Treatment), BioTICLA Laboratory (Precision Medicine for Ovarian Cancers), 3 Avenue du Général Harris, BP 45026, 14 076, Caen, Cedex 05, France.; UNICANCER, Comprehensive Cancer Center François Baclesse, Caen, France., Giffard F; Université de Caen Normandie, INSERM U1086 ANTICIPE (Interdisciplinary Research Unit for Cancers Prevention and Treatment), BioTICLA Laboratory (Precision Medicine for Ovarian Cancers), 3 Avenue du Général Harris, BP 45026, 14 076, Caen, Cedex 05, France.; UNICANCER, Comprehensive Cancer Center François Baclesse, Caen, France., Brotin E; Université de Caen Normandie, Services Unit PLATON, ImpedanCell Core Facility, Caen, France., Denoyelle C; Université de Caen Normandie, INSERM U1086 ANTICIPE (Interdisciplinary Research Unit for Cancers Prevention and Treatment), BioTICLA Laboratory (Precision Medicine for Ovarian Cancers), 3 Avenue du Général Harris, BP 45026, 14 076, Caen, Cedex 05, France.; UNICANCER, Comprehensive Cancer Center François Baclesse, Caen, France.; Université de Caen Normandie, Services Unit PLATON, ImpedanCell Core Facility, Caen, France., Villenet C; University of Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, US 41 - UAR 2014 - PLBS, Lille, France., Sebda S; University of Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, US 41 - UAR 2014 - PLBS, Lille, France., Briand M; Université de Caen Normandie, INSERM U1086 ANTICIPE (Interdisciplinary Research Unit for Cancers Prevention and Treatment), BioTICLA Laboratory (Precision Medicine for Ovarian Cancers), 3 Avenue du Général Harris, BP 45026, 14 076, Caen, Cedex 05, France.; UNICANCER, Comprehensive Cancer Center Francois Baclesse, Biological Resources Center 'OvaRessources', Caen, France., Joly F; UNICANCER, Comprehensive Cancer Center Francois Baclesse, Clinical Research Department, Caen, France., Dolivet E; Université de Caen Normandie, INSERM U1086 ANTICIPE (Interdisciplinary Research Unit for Cancers Prevention and Treatment), BioTICLA Laboratory (Precision Medicine for Ovarian Cancers), 3 Avenue du Général Harris, BP 45026, 14 076, Caen, Cedex 05, France.; UNICANCER, Comprehensive Cancer Center Francois Baclesse, Department of Surgery, Caen, France., Goux D; Université de Caen Normandie, Services Unit EMERODE, « Centre de Microscopie Appliquée À La Biologie » CMAbio3, Caen, France., Blanc-Fournier C; Université de Caen Normandie, INSERM U1086 ANTICIPE (Interdisciplinary Research Unit for Cancers Prevention and Treatment), BioTICLA Laboratory (Precision Medicine for Ovarian Cancers), 3 Avenue du Général Harris, BP 45026, 14 076, Caen, Cedex 05, France.; UNICANCER, Comprehensive Cancer Center Francois Baclesse, Biological Resources Center 'OvaRessources', Caen, France.; UNICANCER, Comprehensive Cancer Center Francois Baclesse, Department of Biopathology, Caen, France., Jeanne C; UNICANCER, Comprehensive Cancer Center Francois Baclesse, Department of Biopathology, Caen, France., Villedieu M; Université de Caen Normandie, INSERM U1086 ANTICIPE (Interdisciplinary Research Unit for Cancers Prevention and Treatment), BioTICLA Laboratory (Precision Medicine for Ovarian Cancers), 3 Avenue du Général Harris, BP 45026, 14 076, Caen, Cedex 05, France., Meryet-Figuiere M; Université de Caen Normandie, INSERM U1086 ANTICIPE (Interdisciplinary Research Unit for Cancers Prevention and Treatment), BioTICLA Laboratory (Precision Medicine for Ovarian Cancers), 3 Avenue du Général Harris, BP 45026, 14 076, Caen, Cedex 05, France.; UNICANCER, Comprehensive Cancer Center François Baclesse, Caen, France., Figeac M; University of Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, US 41 - UAR 2014 - PLBS, Lille, France., Poulain L; Université de Caen Normandie, INSERM U1086 ANTICIPE (Interdisciplinary Research Unit for Cancers Prevention and Treatment), BioTICLA Laboratory (Precision Medicine for Ovarian Cancers), 3 Avenue du Général Harris, BP 45026, 14 076, Caen, Cedex 05, France. l.poulain@baclesse.unicancer.fr.; Université de Caen Normandie, Services Unit PLATON, ORGAPRED Core Facility, Caen, France. l.poulain@baclesse.unicancer.fr.; UNICANCER, Comprehensive Cancer Center Francois Baclesse, Biological Resources Center 'OvaRessources', Caen, France. l.poulain@baclesse.unicancer.fr., Weiswald LB; Université de Caen Normandie, INSERM U1086 ANTICIPE (Interdisciplinary Research Unit for Cancers Prevention and Treatment), BioTICLA Laboratory (Precision Medicine for Ovarian Cancers), 3 Avenue du Général Harris, BP 45026, 14 076, Caen, Cedex 05, France. lb.weiswald@baclesse.unicancer.fr.; Université de Caen Normandie, Services Unit PLATON, ORGAPRED Core Facility, Caen, France. lb.weiswald@baclesse.unicancer.fr.; UNICANCER, Comprehensive Cancer Center François Baclesse, Caen, France. lb.weiswald@baclesse.unicancer.fr.
Publikováno v:
Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2023 Oct 07; Vol. 42 (1), pp. 260. Date of Electronic Publication: 2023 Oct 07.
Autor:
Elie N; Normandie Univ, UNICAEN, Federative Structure 4207 'Normandie Oncologie', PLATON Services Unit, Virtual'His platform, Caen, France.; Normandie Univ, UNICAEN, Federative Structure 4207 'Normandie Oncologie', PLATON Services Unit, Caen, France., Giffard F; Normandie Univ, UNICAEN, Federative Structure 4207 'Normandie Oncologie', PLATON Services Unit, Virtual'His platform, Caen, France.; Normandie Univ, UNICAEN, Federative Structure 4207 'Normandie Oncologie', PLATON Services Unit, Caen, France.; Normandie Univ, UNICAEN, Inserm U1086 ANTICIPE, Interdisciplinary Research Unit for Cancer Prevention and Treatment, Federative Structure 4207 'Normandie Oncologie', F. Baclesse Comprehensive Cancer Centre, Caen, France.; UNICANCER, F. Baclesse Comprehensive Cancer Centre, Caen, France., Blanc-Fournier C; UNICANCER, F. Baclesse Comprehensive Cancer Centre, Caen, France.; UNICANCER, F. Baclesse Comprehensive Cancer Centre, Biopathology Department, Caen, France., Morice PM; Normandie Univ, UNICAEN, Inserm U1086 ANTICIPE, Interdisciplinary Research Unit for Cancer Prevention and Treatment, Federative Structure 4207 'Normandie Oncologie', F. Baclesse Comprehensive Cancer Centre, Caen, France., Brachet PE; UNICANCER, F. Baclesse Comprehensive Cancer Centre, Caen, France., Dutoit S; Normandie Univ, UNICAEN, Inserm U1086 ANTICIPE, Interdisciplinary Research Unit for Cancer Prevention and Treatment, Federative Structure 4207 'Normandie Oncologie', F. Baclesse Comprehensive Cancer Centre, Caen, France., Plancoulaine B; Normandie Univ, UNICAEN, Inserm U1086 ANTICIPE, Interdisciplinary Research Unit for Cancer Prevention and Treatment, Federative Structure 4207 'Normandie Oncologie', F. Baclesse Comprehensive Cancer Centre, Caen, France.; Department of Pathology, Forensic Medicine and Pharmacology, Institute of Biomedical Sciences of the Faculty of Medicine, Vilnius University, Vilnius, Lithuania., Poulain L; Normandie Univ, UNICAEN, Federative Structure 4207 'Normandie Oncologie', PLATON Services Unit, Caen, France.; Normandie Univ, UNICAEN, Inserm U1086 ANTICIPE, Interdisciplinary Research Unit for Cancer Prevention and Treatment, Federative Structure 4207 'Normandie Oncologie', F. Baclesse Comprehensive Cancer Centre, Caen, France.; UNICANCER, F. Baclesse Comprehensive Cancer Centre, Caen, France.
Publikováno v:
Frontiers in oncology [Front Oncol] 2022 Oct 11; Vol. 12, pp. 931035. Date of Electronic Publication: 2022 Oct 11 (Print Publication: 2022).
Autor:
Chabert, C., Touron, E., Saturnin, A., Krivtchik, G., Girotto, J.-L., Mathonnière, G., Eschback, R., Gabriel, S., Martin, G., Miranda, P., Courtin, F., Allou, A., Boccaccio, R., Giffard, F.-X., Bonin, A., Casoli, P., Laugier, F., Carlier, B., Senentz, G.
Publikováno v:
Global/Top Fuel 2019
Global/Top Fuel 2019, Sep 2019, Seattle, United States
Global/Top Fuel 2019, Sep 2019, Seattle, United States
International audience; In accordance with the French Act of 28 June 2006 on the sustainable management of radioactive materials andwaste, this paper summarises the technical characterisation of prospective scenarios using different fuel cycleoptions
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::8106d1b1e9b06af8c0339242d058d1b8
https://hal-cea.archives-ouvertes.fr/cea-02614134
https://hal-cea.archives-ouvertes.fr/cea-02614134
Autor:
Joly F; Centre François Baclesse, UNICANCER, 3 avenue Général Harris, 14000 Caen, France; Normandie University, UNICAEN, INSERM U1086 'ANTICIPE' (Interdisciplinary Research Unit for Cancers Prevention and Treatment), Centre François Baclesse, 3 avenue Général Harris, 14000 Caen, France. Electronic address: f.joly@baclesse.unicancer.fr., Fabbro M; Institut du Cancer Val d'Aurelle, UNICANCER, 208 rue des Apothicaires, 34298 Montpellier, France. Electronic address: michel.fabbro@icm.unicancer.fr., Follana P; Centre Antoine Lacassagne, UNICANCER, 33 avenue de Valombrose, 06189 Nice, France. Electronic address: philippe.follana@nice.unicancer.fr., Lequesne J; Centre François Baclesse, UNICANCER, 3 avenue Général Harris, 14000 Caen, France. Electronic address: j.lequesne@baclesse.unicancer.fr., Medioni J; Assistance Publique - Hôpitaux de Paris, Hôpital Européen Georges Pompidou, 20 Rue Leblanc, 75015 Paris, France; UFR de Médecine Paris Centre, Université de Paris, UMR_S1138-INSERM, France. Electronic address: jacques.medioni@aphp.fr., Lesoin A; Centre Oscar Lambret, UNICANCER, 3 rue Frédéric Combemale, 59000 Lille, France. Electronic address: a-lesoin@o-lambret.fr., Frenel JS; Institut de Cancérologie de l'Ouest, Centre René Gauducheau, UNICANCER, Boulevard Professeur Jacques Monod, 44805 Saint-Herblain, France. Electronic address: jean-sebastien.frenel@ico.unicancer.fr., Abadie-Lacourtoisie S; Institut de Cancérologie de l'Ouest, Centre Paul Papin, UNICANCER, 15 rue Bocquel 49055 Angers cedex, France. Electronic address: sophie.abadie-lacourtoisie@ico.unicancer.fr., Floquet A; Institut Bergonié, UNICANCER, 229 Cours de l'Argonne, 33076 Bordeaux, France. Electronic address: a.floquet@bordeaux.unicancer.fr., Gladieff L; Institut Claudius Regaud, UNICANCER, Institut Universitaire du Cancer de Toulouse Oncopole, 1 Avenue Irène Joliot-Curie, 31059 Toulouse, France. Electronic address: gladieff.laurence@iuct-oncopole.fr., You B; CITOHL, Centre Hospitalier Lyon Sud, Institut de Cancérologie des Hospices Civils de Lyon (IC-HCL), 69310 Pierre-Bénite, France; Université Claude Bernard Lyon 1, UCBL, EA3738 CICLY, Lyon, France. Electronic address: benoit.you@chu-lyon.fr., Gavoille C; Institut de Cancérologie de Lorraine, UNICANCER, 6 Avenue de Bourgogne Brabois, 54511 Vandoeuvre-lès-Nancy, France. Electronic address: c.gavoille@nancy.unicancer.fr., Kalbacher E; Centre Hospitalier Universitaire Jean Minjoz, 3 boulevard Alexandre Fleming, 25030 Besançon, France. Electronic address: ekalbacher@chu-besancon.fr., Briand M; Centre François Baclesse, UNICANCER, 3 avenue Général Harris, 14000 Caen, France; Normandie University, UNICAEN, INSERM U1086 'ANTICIPE' (Interdisciplinary Research Unit for Cancers Prevention and Treatment), Centre François Baclesse, 3 avenue Général Harris, 14000 Caen, France. Electronic address: m.briand@baclesse.unicancer.fr., Brachet PE; Centre François Baclesse, UNICANCER, 3 avenue Général Harris, 14000 Caen, France; Normandie University, UNICAEN, INSERM U1086 'ANTICIPE' (Interdisciplinary Research Unit for Cancers Prevention and Treatment), Centre François Baclesse, 3 avenue Général Harris, 14000 Caen, France. Electronic address: pe.brachet@baclesse.unicancer.fr., Giffard F; Centre François Baclesse, UNICANCER, 3 avenue Général Harris, 14000 Caen, France; Normandie University, UNICAEN, INSERM U1086 'ANTICIPE' (Interdisciplinary Research Unit for Cancers Prevention and Treatment), Centre François Baclesse, 3 avenue Général Harris, 14000 Caen, France. Electronic address: giffard-f@baclesse.unicancer.fr., Weiswald LB; Centre François Baclesse, UNICANCER, 3 avenue Général Harris, 14000 Caen, France; Normandie University, UNICAEN, INSERM U1086 'ANTICIPE' (Interdisciplinary Research Unit for Cancers Prevention and Treatment), Centre François Baclesse, 3 avenue Général Harris, 14000 Caen, France. Electronic address: lb.weiswald@baclesse.unicancer.fr., Just PA; Université de Paris, APHP, Cochin Hospital, 27 rue du Faubourg Saint-Jacques, 75014 Paris, France. Electronic address: pierre-alexandre.just@aphp.fr., Blanc-Fournier C; Centre François Baclesse, UNICANCER, 3 avenue Général Harris, 14000 Caen, France; Normandie University, UNICAEN, INSERM U1086 'ANTICIPE' (Interdisciplinary Research Unit for Cancers Prevention and Treatment), Centre François Baclesse, 3 avenue Général Harris, 14000 Caen, France. Electronic address: c.blanc.fournier@baclesse.unicancer.fr., Leconte A; Centre François Baclesse, UNICANCER, 3 avenue Général Harris, 14000 Caen, France. Electronic address: a.leconte@baclesse.unicancer.fr., Clarisse B; Centre François Baclesse, UNICANCER, 3 avenue Général Harris, 14000 Caen, France. Electronic address: b.clarisse@baclesse.unicancer.fr., Leary A; Institut Gustave Roussy, UNICANCER, 39 rue Camille Desmoulins, 94805 Villejuif, France. Electronic address: alexandra.leary@gustaveroussy.fr., Poulain L; Centre François Baclesse, UNICANCER, 3 avenue Général Harris, 14000 Caen, France; Normandie University, UNICAEN, INSERM U1086 'ANTICIPE' (Interdisciplinary Research Unit for Cancers Prevention and Treatment), Centre François Baclesse, 3 avenue Général Harris, 14000 Caen, France. Electronic address: l.poulain@baclesse.unicancer.fr.
Publikováno v:
Gynecologic oncology [Gynecol Oncol] 2022 Apr; Vol. 165 (1), pp. 30-39. Date of Electronic Publication: 2022 Feb 02.
Autor:
Ciappuccini, R., Saguet-Rysanek, V., Giffard, F., Licaj, I., Dorbeau, M., Clarisse, B., Poulain, L., Bardet, S.
Publikováno v:
In Annales d'Endocrinologie October 2021 82(5):258-258
Autor:
Ciappuccini R; Department of Nuclear Medicine and Thyroid Unit, Comprehensive Cancer Centre François Baclesse, 14000 Caen, France.; Normandie University, UNICAEN, INSERM U1086 ANTICIPE (Interdisciplinary Research Unit for Cancers Prevention and Treatment), 14000 Caen, France., Saguet-Rysanek V; Department of Pathology, Comprehensive Cancer Centre François Baclesse, 14000 Caen, France., Giffard F; Normandie University, UNICAEN, INSERM U1086 ANTICIPE (Interdisciplinary Research Unit for Cancers Prevention and Treatment), 14000 Caen, France.; UNICANCER, Comprehensive Cancer Centre François Baclesse, 14000 Caen, France., Licaj I; Normandie University, UNICAEN, INSERM U1086 ANTICIPE (Interdisciplinary Research Unit for Cancers Prevention and Treatment), 14000 Caen, France.; Department of Clinical Research, Comprehensive Cancer Centre François Baclesse, 14000 Caen, France.; Department of Community Medicine, Faculty of Health Sciences, The UiT Arctic University of Norway, 9010 Tromsø, Norway., Dorbeau M; Department of Pathology, Comprehensive Cancer Centre François Baclesse, 14000 Caen, France., Clarisse B; Department of Clinical Research, Comprehensive Cancer Centre François Baclesse, 14000 Caen, France., Poulain L; Normandie University, UNICAEN, INSERM U1086 ANTICIPE (Interdisciplinary Research Unit for Cancers Prevention and Treatment), 14000 Caen, France.; UNICANCER, Comprehensive Cancer Centre François Baclesse, 14000 Caen, France., Bardet S; Department of Nuclear Medicine and Thyroid Unit, Comprehensive Cancer Centre François Baclesse, 14000 Caen, France.
Publikováno v:
The Journal of clinical endocrinology and metabolism [J Clin Endocrinol Metab] 2021 Nov 19; Vol. 106 (12), pp. 3536-3545.